Neurocrine Biosciences Stock Forecast

Buy or Hold candidate since Nov 19, 2024 Gain 6.12%

The Neurocrine Biosciences stock price fell by -1.03% on the last day (Thursday, 5th Dec 2024) from $127.74 to $126.42. During the last trading day the stock fluctuated 1.65% from a day low at $125.74 to a day high of $127.82. The price has risen in 6 of the last 10 days and is up by 2.54% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -120 thousand shares and in total, 512 thousand shares were bought and sold for approximately $64.69 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.59% during the next 3 months and, with a 90% probability hold a price between $126.34 and $139.48 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

NBIX Signals & Forecast

The Neurocrine Biosciences stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $126.68. On a fall, the stock will find some support from the long-term average at approximately $122.21. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, November 26, 2024, and so far it has fallen -1.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Tuesday, October 29, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Neurocrine Biosciences stock

Neurocrine Biosciences finds support from accumulated volume at $124.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.08 (1.65%) between high and low. For the last week, the stock has had daily average volatility of 1.59%.

Our recommended stop-loss: $121.15 (-4.17%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (NBIX) For The Upcoming Trading Day Of Friday 6th

For the upcoming trading day on Friday, 6th we expect Neurocrine Biosciences to open at $126.66, and during the day (based on 14 day Average True Range), to move between $123.49 and $129.35, which gives a possible trading interval of +/-$2.93 (+/-2.32%) up or down from last closing price. If Neurocrine Biosciences takes out the full calculated possible swing range there will be an estimated 4.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $127.01 (0.47%) than the support at $124.33 (1.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neurocrine Biosciences stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Neurocrine Biosciences stock to perform well in the short-term.

Current score: 1.962 Buy Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on December 6, 2024 - $126.66 ( 0.190%).